Dublin, Jan. 15, 2026 (GLOBE NEWSWIRE) -- The "Rare Cell Isolation Market Forecast to 2033" report has been added to ResearchAndMarkets.com's offering.
The global rare cell isolation market size was valued at USD 2.02 billion in 2024 and is projected to reach USD 5.09 billion by 2033, growing at a CAGR of 10.85% from 2025 to 2033.
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033.
The rare cell isolation market has been experiencing significant growth, driven by advancements in biotechnology and the increasing need for precision medicine. Rare cells, which include circulating tumor cells (CTCs), stem cells, and fetal cells, play crucial roles in early disease detection, treatment monitoring, and personalized therapy.
Why You Should Buy This Report
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 120 |
| Forecast Period | 2024 - 2033 |
| Estimated Market Value (USD) in 2024 | $2.02 Billion |
| Forecasted Market Value (USD) by 2033 | $5.09 Billion |
| Compound Annual Growth Rate | 10.8% |
| Regions Covered | Global |
Rare cell isolation market Variables, Trends & Scope
- Market Lineage Outlook
- Parent market outlook
- Related/ancillary market outlook.
- Market Dynamics
- Market driver analysis
- Rising prevalence of chronic and rare diseases
- Technological advancement and innovation in cell isolation
- Market restraint analysis
- Strict regulations and compliances for cell separation
- Rare Cell Isolation Market Analysis Tools
- Industry Analysis - Porter's
- PESTEL Analysis
Products Outlook (Revenue, USD Million, 2021-2033)
- Reagent & Kits
- Instrument
Cell Type Outlook (Revenue, USD Million, 2021-2033)
- Circulating Tumor Cells
- Stem Cells
- Fetal Cells
- Rare Immune Cells
- Circulating Endothelial Cells
- Other Rare Cell Types
Technology Outlook (Revenue, USD Million, 2021-2033)
- Magnetic Bead Separation
- Fluorescence-Activated Cell Sorting
- Microfluidics-based techniques
Regional Outlook (Revenue, USD Million, 2021-2033)
- North America
- Europe
- Asia-Pacific
- Latin America
- MEA
Companies Featured
- Miltenyi Biotec
- Thermo Fisher Scientific, Inc.
- Danaher
- QIAGEN N.V.
- Bio-techne
- STEMCELL Technologies
- CELLENION
- RareCyte
- Illumina, Inc.
- Bio-Rad Laboratories, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/gn5kcb
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
